Insulin receptor substrate (IRS)-1 regulates murine embryonic stem (mES) cells self-renewal

Journal of Cellular Physiology

Volumn 213, Issue 2, 2007, Pages 445-453

  Rubin, Raphael ^a   Arzumanyan, Alla ^a   Soliera, Angela Rachele ^a,b   Ross, Brian ^a   Peruzzi, Francesca ^c   Prisco, Marco ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; GLYCOGEN SYNTHASE KINASE 3; INHIBITOR OF DIFFERENTIATION 1; INHIBITOR OF DIFFERENTIATION 2; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; LEUKEMIA INHIBITORY FACTOR; OCTAMER TRANSCRIPTION FACTOR 4; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL RENEWAL; CONTROLLED STUDY; DOWN REGULATION; EMBRYONIC STEM CELL; ENZYME ACTIVITY; GENE EXPRESSION; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REGULATORY MECHANISM; RETROVIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BIOLOGICAL MARKERS; CELL CYCLE; CELL DIFFERENTIATION; CELLS, CULTURED; EMBRYONIC STEM CELLS; LEUKEMIA INHIBITORY FACTOR; MICE; OCTAMER TRANSCRIPTION FACTOR-3; PHOSPHOPROTEINS; PHOSPHORYLATION; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

MURINAE;

EID: 34848868143     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21185     Document Type: Article

References (58)

1. Araki E, Lipes MA, Patti ME, Bruning JC, Haag B III, Johnson RS, Kahn CR. 1994. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186-190.
2. Argetsinger LS, Hsu GW, Myers MG, Jr., Billestrup N, White MF, Carter-Su C. 1995. Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. J Biol Chem 270:14685-14692.
3. Baserga R. 2000. The contradictions of the insulin-like growth factor I receptor. Oncogene 19:5574-5581.
4. Baserga R. 2005. The insulin-like growth factor-I receptor as a target for cancer therapy. Expert Opin Ther Targets 9:753-768.
5. Belletti B, Prisco M, Morrione A, Valentinis B, Navarro M, Baserga R. 2001. Regulation of Id2 gene expression by the insulin-like growth factor I receptor requires signaling by phosphatidylinositol 3-kinase. J Biol Chem 276:13867-13874.
6. Belletti B, Drakas R, Morrione A, Tu X, Prisco M, Yuan T, Casaburi I, Baserga R. 2002. Regulation of Id1 protein expression in mouse embryo fibroblasts by the type I insulin-like growth factor receptor. Exp Cell Res 277:107-118.
7. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. 1990. The protein Id: A negative regulator of helix-loop-helix DNA binding proteins. Cell 61:49-59.
8. Boeuf H, Hauss C, Graeve FD, Baran N, Kedinger C. 1997. Leukemia inhibitory factor-dependent transcriptional activation in embryonic stem cells. J Cell Biol 138:1207-1217.
9. Bohni R, Riesgo-Escovar J, Oldham S, Brogiolo W, Stocker H, Andruss BF, Beckingham K, Hafen E. 1999. Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS 1-4. Cell 97:865-875.
10. Bradley A, Evans M, Kaufman MH, Robertson E. 1984. Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 309:255-256.
11. Brogiolo W, Stocker H, Ikeya T, Rintelen F, Fernandez R, Hafen E. 2001. An evolutionarily conserved function of the Drosophila insulin receptor and insulin-like peptides in growth control. Curr Biol 11:213-221.
12. Burdon T, Stracey C, Chambers I, Nichols J, Smith A. 1999. Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev Biol 210:30-43.
13. Burdon T, Smith A, Savatier P. 2002. Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol 12:432-438.
14. Cartwright P, McLean C, Sheppard A, Rivett D, Jones K, Dalton S. 2005. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 132:885-896.
15. Cengel KA, Freund GG. 1999. JAK1-dependent phosphorylation of insulin receptor substrate-1 (IRS-1) is inhibited by IRS-1 serine phosphorylation. J Biol Chem 274:27969-27974.
16. Chang Q, Li Y, White MF, Fletcher JA, Xiao S. 2002. Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: Therapeutic implications. Cancer Res 62:6035-6038
17. Ernst M, Oates A, Dunn AR. 1996. Gp130-mediated signal transduction in embryonic stem cells involves activation of Jak and Ras/mitogen-activated protein kinase pathways. J Biol Chem 271:30136-30143.
18. Esposito DL, Li Y, Vanni C, Mammarella S, Veschi S, Della Loggia F, Mariani-Costantini R, Battista P, Quon MJ, Cama A. 2003. A novel T608R missense mutation in insulin receptor substrate-1 identified in a subject with type 2 diabetes impairs metabolic insulin signaling. J Clin Endocrinol Metab 88:1468-1475.
19. Evans MJ. 1981. Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154-156
20. Keller GM. 1995 In vitro differentiation of embryonic stem cells. Curr Opin Cell Biol 7:862-869.
21. Kim B, Leventhal PS, White MF, Feldman EL. 1998. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells. Endocrinology 139:4881-4889.
22. Kreider BL, Benezra R, Rovera G, Kadesch T. 1992. Inhibition of myeloid differentiation by the helix-loop-helix protein Id. Science 255:1700-1702.
23. Lister J, Forrester WC, Baron MH. 1995. Inhibition of an erythroid differentiation switch by the helix-loop-helix protein Id1. J Biol Chem 270:17939-17946.
24. Martin GR. 1981. Isolation of a pluripotent cell line from early mouse embryos cultured in mediumconditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 78:7634-7638.
25. Matsuda T, Nakamura T, Nakao K, Arai T, Katsuki M, Heike T, Yokota T. 1999. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J 18:4261-4269.
26. Mummery CL, van den Eijnden-van Raaij AJ, Feijen A, Freund E, Hulskotte E, Schoorlemmer J, Kruijer W. 1990. Expression of growth factors during the differentiation of embryonic stem cells in monolayer. Dev Biol 142:406-413.
27. Myers MG, Jr., Grammer TC, Wang LM, Sun XJ, Pierce JH, Blenis J, White MF. 1994. Insulin receptor substrate-1 mediates phosphatidylinositol 3′-kinase and p70S6k signaling during insulin, insulin-like growth factor-1, and interleukin-4 stimulation. J Biol Chem 269:28783-28789.
28. Navarro M, Valentinis B, Belletti B, Romano G, Reiss K, Baserga R. 2001. Regulation of Id2 gene expression by the type I IGF receptor and the insulin receptor substrate-1. Endocrinology 142:5149-5157.
29. Nichols J, Evans EP, Smith AG. 1990. Establishment of germ-line-competent embryonic stem (ES) cells using differentiation inhibiting activity. Development 110:1341-1348.
30. Niwa H, Burdon T, Chambers I, Smith A. 1998. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev 12:2048-2060.
31. Nozaki T, Masutani M, Watanabe M, Ochiya T, Hasegawa F, Nakagama H, Suzuki H, Sugimura T. 1999. Syncytiotrophoblastic giant cells in teratocarcinoma-like tumors derived from Parp-disrupted mouse embryonic stem cells. Proc Natl Acad Sci USA 96:13345-13350.
32. Paling NR, Wheadon H, Bone HK, Welham MJ. 2004. Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signaling. J Biol Chem 279:48063-48070.
33. Pederson TM, Kramer DL, Rondinone CM. 2001. Serine/threonine phosphorylation of IRS-1 triggers its degradation: Possible regulation by tyrosine phosphorylation. Diabetes 50:24-31.
34. Prisco M, Peruzzi F, Belletti B, Baserga R. 2001. Regulation of Id gene expression by type I insulin-like growth factor: Roles of Stat3 and the tyrosine 950 residue of the receptor. Mol Cell Biol 21:5447-5458.
35. Prisco M, Maiorana A, Guerzoni C, Calin G, Calabretta B, Voit R, Grummt I, Baserga R. 2004. Role of pescadillo and upstream binding factor in the proliferation and differentiation of murine myeloid cells. Mol Cell Biol 24:5421-5433.
36. Qu CK, Feng GS. 1998. Shp-2 has a positive regulatory role in ES cell differentiation and proliferation. Oncogene 17:433-439.
37. Raz R, Lee CK, Cannizzaro LA, d'Eustachio P, Levy DE. 1999. Essential role of STAT3 for embryonic stem cell pluripotency. Proc Natl Acad Sci USA 96:2846-2851.
38. Ruzinova MB, Benezra R. 2003. Id proteins in development, cell cycle and cancer. Trends Cell Biol 13:410-418.
39. Sadowski CL, Choi TS, Le M, Wheeler TT, Wang LH, Sadowski HB. 2001. Insulin Induction of SOCS-2 and SOCS-3 mRNA expression in C2C12 skeletal muscle cells is mediated by Stat5*. J Biol Chem 276:20703-20710.
40. Saito S, Liu B, Yokoyama K. 2004. Animal embryonic stem (ES) cells: Self-renewal, pluripotency, transgenesis and nuclear transfer. Hum Cell 17:107-115.
41. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH. 2004. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 10:55-63.
42. Saxton TM, Henkemeyer M, Gasca S, Shen R, Rossi DJ, Shalaby F, Feng GS, Pawson T. 1997. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. EMBO J 16:2352-2364.
43. Shi CZ, Collins HW, Buettger CW, Garside WT, Matschinsky FM, Heyner S. 1994. Insulin family growth factors have specific effects on protein synthesis in preimplantation mouse embryos. Mol Reprod Dev 37:398-406.
44. Shima H, Pende M, Chen Y, Fumagalli S, Thomas G, Kozma SC. 1998. Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J 17:6649-6659.
45. Starr R, Novak U, Willson TA, Inglese M, Murphy V, Alexander WS, Metcalf D, Nicola NA, Hilton DJ, Ernst M. 1997. Distinct roles for leukemia inhibitory factor receptor alpha-chain and gp130 in cell type-specific signal transduction. J Biol Chem 272:19982-19986.
46. Sun XJ, Crimmins DL, Myers MG, Jr., Miralpeix M, White MF. 1993. Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1. Mol Cell Biol 13:7418-7428.
47. Suzuki R, Tobe K, Aoyama M, Inoue A, Sakamoto K, Yamauchi T, Kamon J, Kubota N, Terauchi Y, Yoshimatsu H, Matsuhisa M, Nagasaka S, Ogata H, Tokuyama K, Nagai R, Kadowaki T. 2004. Both insulin signaling defects in the liver and obesity contribute to insulin resistance and cause diabetes in Irs2(-/-) mice. J Biol Chem 279:25039-25049.
48. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S., et al. 1994. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372:182-186.
49. Toomey JR, Kratzer KE, Lasky NM, Broze GJ, Jr. 1997. Effect of tissue factor deficiency on mouse and tumor development. Proc Natl Acad Sci USA 94:6922-6926.
50. Valentinis B, Romano G, Peruzzi F, Morrione A, Prisco M, Soddu S, Cristofanelli B, Sacchi A, Baserga R. 1999. Growth and differentiation signals by the insulin-like growth factor I receptor in hemopoietic cells are mediated through different pathways J Biol Chem 274:12423-12430.
51. Valentinis B, Navarro M, Zanocco-Marani T, Edmonds P, McCormick J, Morrione A, Sacchi A, Romano G, Reiss K, Baserga R. 2000. Insulin receptor substrate-1, p70S6K, and cell size in transformation and differentiation of hemopoietic cells. J Biol Chem 275:25451-25459.
52. Valverde AM, Arribas M, Mur C, Navarro P, Pons S, Cassard-Doulcier AM, Kahn CR, Benito M. 2003. Insulin-induced up-regulated uncoupling protein-1 expression is mediated by insulin receptor substrate 1 through the phosphatidylinositol 3-kinase/Akt signaling pathway in fetal brown adipocytes. J Biol Chem 278:10221-10231.
53. Wang LM, Keegan AD, Li W, Lienhard GE, Pacini S, Gutkind JS, Myers MG, Jr., Sun XJ, White MF, Aaronson SA., et al. 1993. Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hematopoietic cells. Proc Natl Acad Sci USA 90: 4032-4036.
54. Watanabe S, Umehara H, Murayama K, Okabe M, Kimura T, Nakano T. 2006. Activation of Akt signaling is sufficient to maintain pluripotency in mouse and primate embryonic stem cells. Oncogene 25:2697-2707.
55. White MF. 1998. The IRS-signalling system: A network of docking proteins that mediate insulin action. Mol Cell Biochem 182:3-11.
56. Yamamoto-Honda R, Honda Z, Ueki K, Tobe K, Kaburagi Y, Takahashi Y, Tamemoto H, Suzuki T, Itoh K, Akanuma Y, Yazaki Y, Kadowaki T. 1996. Mutant of insulin receptor substrate-1 incapable of activating phosphatidylinositol 3-kinase did not mediate insulin-stimulated maturation of Xenopus laevis oocytes. J Biol Chem 271:28677-28681.
57. Yenush L, Zanella C, Uchida T, Bernal D, White MF. 1998. The pleckstrin homology and phosphotyrosine binding domains of insulin receptor substrate 1 mediate inhibition of apoptosis by insulin. Mol Cell Biol 18:6784-6794.
58. Ying QL, Nichols J, Chambers I, Smith A. 2003. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115:281-292.